This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Corteva, Inc. provides agriculture products. The company develops and supplies germplasm and traits in corn, soybean and sunflower seed markets. It also supplies products to the agricultural input industry which protect against weeds, insects and other pests, and diseases as well as to enhance crop health. Corteva, Inc. is based in Wilmington, Delaware.
Should You Invest in the First Trust Consumer Staples AlphaDEX ETF (FXG)?
by Zacks Equity Research
Sector ETF report for FXG
DOLE vs. CTVA: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
DOLE vs. CTVA: Which Stock Is the Better Value Option?
Clorox (CLX) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Elevated manufacturing and logistics costs might have hurt Clorox's (CLX) bottom line in third-quarter fiscal 2022. Nonetheless, its IGNITE strategy appears encouraging.
Corteva, Inc. (CTVA) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Corteva, Inc. (CTVA) delivered earnings and revenue surprises of 19.75% and 1.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Can Higher Costs Mar Monster Beverage's (MNST) Earnings in Q1?
by Zacks Equity Research
Strength in the energy drinks business and higher demand are likely to have boosted Monster Beverage's (MNST) sales in Q1. Higher operating costs and supply-chain headwinds are expected to have hurt.
AB InBev (BUD) to Report Q1 Earnings: What's on the Cards?
by Zacks Equity Research
AB InBev's (BUD) Q1 results are expected to reflect gains from volume, pricing and revenue per hl growth, as well as strength in the beer category, amid supply-chain and cost headwinds.
Clorox (CLX) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Elevated manufacturing and logistics costs might have hurt Clorox's (CLX) bottom line in third-quarter fiscal 2022. Nonetheless, its IGNITE strategy appears encouraging.
Factors Likely to Influence Molson Coors' (TAP) Q1 Earnings
by Zacks Equity Research
Molson Coors (TAP) Q1 results are likely to reflect gains from the revitalization plan and portfolio premiumization. Higher marketing and inflationary costs are likely to have hurt performance.
FEMSA (FMX) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
FEMSA's (FMX) Q1 results are expected to reflect gains from strength across business units, market recovery, digital growth and expansion amid supply-chain woes and higher raw material costs.
Corteva, Inc. (CTVA) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Corteva, Inc. (CTVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors Likely to Influence Keurig (KDP) in Q1 Earnings
by Zacks Equity Research
Keurig's (KDP) Q1 results are likely to reflect solid demand, and in-market performance across categories and brands. Inflationary costs and supply-chain woes are likely to have hurt.
Factors Likely to Influence Newell (NWL) in Q1 Earnings
by Zacks Equity Research
Higher costs, inflationary pressure and supply-chain woes are likely to have hurt Newell's (NWL) Q1 performance. Robust consumption, strong demand and core sales growth are likely to have aided.
Factors to Decide Archer Daniels' (ADM) Fate in Q1 Earnings
by Zacks Equity Research
Archer Daniels' (ADM) Q1 results are likely to reflect gains from solid demand, continued strength in the Nutrition segment and efforts to expand its solutions portfolio via buyouts and partnerships.
Factors Likely to Affect Procter & Gamble's (PG) Q3 Earnings
by Zacks Equity Research
Procter & Gamble's (PG) Q3 results are expected to reflect gains from strong consumer demand, and productivity and cost-saving initiatives. Higher input and freight costs are likely to have ailed.
Zacks Industry Outlook Highlights: Archer Daniels Midland Company, Corteva Inc., Adecoagro S.A., Calavo Grower and Alico Inc
by Zacks Equity Research
Archer Daniels Midland Company, Corteva Inc., Adecoagro S.A., Calavo Grower and Alico Inc. are highlighted in this Industry Outlook article.
5 Stocks to Watch in a Prospering Agriculture Operations Industry
by Rajani Lohia
The Agriculture - Operations industry looks well-placed for growth, driven by the solid demand for healthy and organic products amid challenging supply-chain conditions and high input costs. Players like ADM, CTVA, AGRO, CVGW and ALCO have placed themselves well.
Corteva, Inc. (CTVA) Q4 Earnings Match Estimates
by Zacks Equity Research
Corteva, Inc. (CTVA) delivered earnings and revenue surprises of 0% and 0.11%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Corteva, Inc. (CTVA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Corteva, Inc. (CTVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Limoneira (LMNR) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of -7.69% and 21.20%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock?
Has Corteva, Inc. (CTVA) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Corteva, Inc. (CTVA) and Coca-Cola (KO) have performed compared to their sector so far this year.
DOLE vs. CTVA: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
DOLE vs. CTVA: Which Stock Is the Better Value Option?
DOLE vs. CTVA: Which Stock Is the Better Value Option?
by Zacks Equity Research
DOLE vs. CTVA: Which Stock Is the Better Value Option?
Corteva, Inc. (CTVA) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Corteva, Inc. (CTVA) delivered earnings and revenue surprises of 57.58% and 17.20%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
B&G Foods (BGS) Queued Up for Q3 Earnings: Key Aspects to Note
by Zacks Equity Research
B&G Foods' (BGS) third-quarter performance is likely to have been affected by higher input costs, such as raw materials and transportation.
Prestige Consumer (PBH) to Post Q2 Earnings: Things to Note
by Zacks Equity Research
Prestige Consumer's (PBH) performance in the fiscal second quarter is likely to have gained from strong brand offerings, especially in healthcare, as well as growing e-commerce sales.